Tango Therapeutics, Inc. (TNGX) Financials

TNGX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 402.6 million 149.5 million
2023-09-30 428.2 million 151.6 million
2023-06-30 379.3 million 166.4 million
2023-03-31 403.8 million 176.5 million

TNGX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -27.7 million 4.9 million
2023-09-30 -31.2 million 4.9 million
2023-06-30 -25.1 million 5.1 million
2023-03-31 -35.5 million 4.2 million

TNGX Net Income

No data available :(

TNGX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 336.9 million - 38.9 million
2023-09-30 359.9 million - 39.5 million
2023-06-30 310.7 million - 39.9 million
2023-03-31 333.6 million - 41.4 million

TNGX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 97.2 million
2023-09-30 97.0 million
2023-06-30 88.4 million
2023-03-31 88.2 million

TNGX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 226000 31.3 million 9.1 million -
2023-09-30 16000 27.1 million 9.2 million -
2023-06-30 664000 28.7 million 9.2 million -
2023-03-31 620000 28.0 million 8.0 million -

TNGX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 5.4 million 617000
2023-09-30 10.7 million 613000
2023-06-30 14.6 million 1.5 million
2023-03-31 5.8 million 1.5 million

TNGX

Price: $7.44

52 week price:
2.47
13.03

Earnings Per Share: -1.08 USD

P/E Ratio: -11.60

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 179400

Market Capitalization: 784.4 million

Links: